RESMED INC
RMDdata completeness 100%18 fiscal years on fileData notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'
RESMED INC earns about 21% on invested capital, far above its ~9% cost of capital, with a roughly flat share count — a real edge showing up in the numbers. The estimate methods put fair value between $71.33 and $660.87 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | $3.58B1 | $4.22B2 | $4.69B3 | $5.15B3 | $5.65B3 |
| Net income | $779.4M4 | $897.6M5 | $1.02B6 | $1.4B6 | $1.52B6 |
| Operating cash flow | $351.1M7 | $693.3M8 | $1.4B9 | $1.75B9 | $1.81B9 |
| Capital expenditure | $134.8M10 | $119.7M11 | $99.5M12 | $89.9M12 | $156.3M12 |
| Free cash flow (derived) | $216.3M7 | $573.6M8 | $1.3B9 | $1.66B9 | $1.65B9 |
| Total debt | $775.2M13 | $1.44B14 | $707.2M15 | $668.3M16 | $659.4M16 |
| Cash & equivalents | $273.7M17 | $227.9M18 | $238.4M19 | $1.21B20 | $1.47B20 |
| Diluted shares | 147.0M | 147.5M | 147.6M | 147.3M | 146.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $450.89 of net worth that earned you $104.3 and generated $112.94 of cash last year, against $45.15 of debt.
It earned about 21% on invested capital, year after year, against a ~9% cost of capital — the footprint of real pricing power. Competition usually drags returns like this back down; here it hasn't.
seeing a moat in the numbers →Share count is roughly flat over 5 years — little dilution, little buyback. Total debt has fallen 15% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
The 3 estimate methods that apply put fair value between $71.33 and $660.87 a share. They rest on different assumptions, so where they diverge is the story; the Graham Number is a stricter floor, not a target.
assumptions (10)
- riskFreeRate4.8%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth20.0%
- fcfBase$1.65B
assumptions (10)
- riskFreeRate4.8%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth20.0%
- fcfBase$1.65B
assumptions (8)
- riskFreeRate4.8%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$1.02B
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
| Bear | 0.0% | $163.39 |
| Base | 20.0% | $365.1 |
| Bull | 20.0% | $365.1 |
Bear/base/bull growth = 0% / filed history / history + 5pp. Type a price to see the return each case implies.
Default growth 20.0%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.
- 10-K · period ending 2022-06-30 · accession 0000943819-24-000013 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-06-30 · accession 0000943819-25-000035 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-06-30 · accession 0000943819-26-000047 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-06-30 · accession 0000943819-24-000013 (NetIncomeLoss)
- 10-K · period ending 2023-06-30 · accession 0000943819-25-000035 (NetIncomeLoss)
- 10-K · period ending 2024-06-30 · accession 0000943819-26-000047 (NetIncomeLoss)
- 10-K · period ending 2022-06-30 · accession 0000943819-24-000013 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-06-30 · accession 0000943819-25-000035 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-06-30 · accession 0000943819-26-000047 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-06-30 · accession 0000943819-24-000013 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-06-30 · accession 0000943819-25-000035 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-06-30 · accession 0000943819-26-000047 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-06-30 · accession 0000943819-23-000011 (LongTermDebt)
- 10-K · period ending 2023-06-30 · accession 0000943819-24-000013 (LongTermDebt)
- 10-K · period ending 2024-06-30 · accession 0000943819-25-000035 (LongTermDebt)
- 10-K · period ending 2025-06-30 · accession 0000943819-26-000047 (LongTermDebt)
- 10-K · period ending 2022-06-30 · accession 0000943819-23-000011 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-06-30 · accession 0000943819-24-000013 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-06-30 · accession 0000943819-25-000035 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-06-30 · accession 0000943819-26-000047 (CashAndCashEquivalentsAtCarryingValue)